6-Methylcoumarin (CAS 92-48-8)

6-Methylcoumarin (6-MC) emerges naturally within a range of plant species, standing as a derivative of coumarin and a prominent member of the coumarin compound family. The manifold biological activities exhibited by 6-Methylcoumarin have garnered substantial research attention, leading to its incorporation into diverse investigative endeavors. The practical employment of 6-Methylcoumarin spans various scientific research scenarios, spanning both in vivo and in vitro investigations. Within in vivo contexts, 6-Methylcoumarin has been employed to scrutinize its effects on the immune, cardiovascular, and neurological systems. In vitro studies, on the other hand, have delved into the influences of 6-Methylcoumarin on cellular growth, programmed cell death, and genetic expression. Though the precise operational framework of 6-Methylcoumarin remains partly veiled, its interaction with diverse cellular targets is hypothesized. Noteworthy among these are the enzyme cyclooxygenase-2 (COX-2), the transcription factor NF-κB, and the enzyme lipoxygenase. Alongside these interactions, 6-MC has demonstrated a capacity to hinder the synthesis of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), and interleukin-6 (IL-6).